Holding(s) in Company

RNS Number : 9655D

Dechra Pharmaceuticals PLC

03 April 2014

 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii				Dechra Pharmaceuticals plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):	Disclosure of revised position following the sale of Scottish Widows Investment Partnership Limited to Aberdeen Asset Management PLC on 31 March 2014				X
3. Full name of person(s) subject to the notification obligation: iii		Lloyds Banking Group plc
4. Full name of shareholder(s)  (if different from 3.):iv		See Section 9
5. Date of the transaction and date on which the threshold is crossed or reached: v		31 March 2014
6. Date on which issuer notified:		2 April 2014
7. Threshold(s) that is/are crossed or reached: vi, vii		Indirect holdings decreased to below 1%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORD GBP0.01

3,257,700

3,257,700

N/A - below reportable threshold

GB0009633180

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

N/A - below reportable threshold

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
N/A - below reportable threshold
Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A
13. Additional information:	Notification using the Total Voting Rights figure of 87,659,263
14. Contact name:	Andrew Kellett
15. Contact telephone number:	0113 235 7729

 

END

 

 

HOLMMGGDLFDGDZG